Biolife Solutions Stock Performance
| BLFS Stock | USD 22.02 0.65 2.87% |
The firm shows a Beta (market volatility) of 1.53, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioLife Solutions will likely underperform. At this point, BioLife Solutions has a negative expected return of -0.26%. Please make sure to confirm BioLife Solutions' information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if BioLife Solutions performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days BioLife Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (2.87) | Five Day Return (1.43) | Year To Date Return (7.83) | Ten Year Return 1.1 K | All Time Return (79.03) |
Last Split Factor 1:14 | Last Split Date 2014-01-29 |
1 | BioLife Solutions Inc Q3 2025 Earnings Call Highlights Strong Revenue Growth and ... | 11/07/2025 |
2 | Disposition of 35417 shares by De Greef Roderick of BioLife Solutions at 26.15 subject to Rule 16b-3 | 11/11/2025 |
3 | Forum Private Client Group LLC Acquires New Holdings in BioLife Solutions, Inc. BLFS - MarketBeat | 11/24/2025 |
4 | Disposition of 30000 shares by Troy Wichterman of BioLife Solutions at 25.72 subject to Rule 16b-3 | 12/04/2025 |
5 | Will CFO Troy Wichtermans Share Sale Amid Stronger Cell Processing Shift BioLife Solutions Narrative | 12/09/2025 |
6 | BioLife Solutions CFO Sells 30,000 Shares | 12/11/2025 |
7 | Disposition of 2000 shares by Duross Amy of BioLife Solutions at 24.6 subject to Rule 16b-3 | 12/15/2025 |
8 | BioLife Solutions Insider Karen Foster Sells 519 Shares of Stock | 12/18/2025 |
9 | Sarah Aebersold Sells 713 Shares of BioLife Solutions Stock | 12/19/2025 |
10 | Disposition of 217 shares by Aebersold Sarah of BioLife Solutions at 26.74 subject to Rule 16b-3 | 12/24/2025 |
11 | Disposition of 1000000 shares by Casdin Partners Master Fund, L.p. of BioLife Solutions at 23.8 subject to Rule 16b-3 | 12/30/2025 |
12 | Biolife Solutions CMO Berard sells 8.8k in shares - Investing.com | 01/08/2026 |
13 | BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations | 01/12/2026 |
14 | BioLife Solutions, Inc. Investor Outlook Highlights 30 percent Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews | 01/27/2026 |
15 | Disposition of 5632 shares by Duross Amy of BioLife Solutions at 24.96 subject to Rule 16b-3 | 01/30/2026 |
| Begin Period Cash Flow | 35.4 M | |
| Total Cashflows From Investing Activities | 58.3 M |
BioLife Solutions Relative Risk vs. Return Landscape
If you would invest 2,629 in BioLife Solutions on November 8, 2025 and sell it today you would lose (427.00) from holding BioLife Solutions or give up 16.24% of portfolio value over 90 days. BioLife Solutions is currently does not generate positive expected returns and assumes 2.5944% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than BioLife, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BioLife Solutions Target Price Odds to finish over Current Price
The tendency of BioLife Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 22.02 | 90 days | 22.02 | about 99.0 |
Based on a normal probability distribution, the odds of BioLife Solutions to move above the current price in 90 days from now is about 99.0 (This BioLife Solutions probability density function shows the probability of BioLife Stock to fall within a particular range of prices over 90 days) .
BioLife Solutions Price Density |
| Price |
Predictive Modules for BioLife Solutions
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioLife Solutions. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioLife Solutions Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioLife Solutions is not an exception. The market had few large corrections towards the BioLife Solutions' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioLife Solutions, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioLife Solutions within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.39 | |
β | Beta against Dow Jones | 1.53 | |
σ | Overall volatility | 1.31 | |
Ir | Information ratio | -0.14 |
BioLife Solutions Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioLife Solutions for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioLife Solutions can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioLife Solutions generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 82.25 M. Net Loss for the year was (20.18 M) with profit before overhead, payroll, taxes, and interest of 64.37 M. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: BioLife Solutions, Inc. Investor Outlook Highlights 30 percent Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews |
BioLife Solutions Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioLife Stock often depends not only on the future outlook of the current and potential BioLife Solutions' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioLife Solutions' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.1 M | |
| Cash And Short Term Investments | 104.6 M |
BioLife Solutions Fundamentals Growth
BioLife Stock prices reflect investors' perceptions of the future prospects and financial health of BioLife Solutions, and BioLife Solutions fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioLife Stock performance.
| Return On Equity | -0.0525 | ||||
| Return On Asset | -0.0073 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 1.02 B | ||||
| Shares Outstanding | 48.15 M | ||||
| Price To Earning | 173.59 X | ||||
| Price To Book | 3.11 X | ||||
| Price To Sales | 10.90 X | ||||
| Revenue | 82.25 M | ||||
| Gross Profit | 64.37 M | ||||
| EBITDA | 1.53 M | ||||
| Net Income | (20.18 M) | ||||
| Cash And Equivalents | 46.55 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 30.17 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 3.55 X | ||||
| Book Value Per Share | 7.38 X | ||||
| Cash Flow From Operations | 8.43 M | ||||
| Earnings Per Share | (0.38) X | ||||
| Market Capitalization | 1.09 B | ||||
| Total Asset | 399.49 M | ||||
| Retained Earnings | (335.1 M) | ||||
| Working Capital | 116.03 M | ||||
| Current Asset | 6.97 M | ||||
| Current Liabilities | 1.73 M | ||||
About BioLife Solutions Performance
Assessing BioLife Solutions' fundamental ratios provides investors with valuable insights into BioLife Solutions' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the BioLife Solutions is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 426.06 | 235.76 | |
| Return On Tangible Assets | (0.10) | (0.11) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.05) | (0.05) |
Things to note about BioLife Solutions performance evaluation
Checking the ongoing alerts about BioLife Solutions for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioLife Solutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioLife Solutions generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 82.25 M. Net Loss for the year was (20.18 M) with profit before overhead, payroll, taxes, and interest of 64.37 M. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: BioLife Solutions, Inc. Investor Outlook Highlights 30 percent Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews |
- Analyzing BioLife Solutions' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioLife Solutions' stock is overvalued or undervalued compared to its peers.
- Examining BioLife Solutions' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioLife Solutions' management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioLife Solutions' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioLife Solutions' stock. These opinions can provide insight into BioLife Solutions' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.